• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

Professional Introduction to 4-(Difluoromethoxy)toluene (CAS No. 1583-83-1)

4-(Difluoromethoxy)toluene, chemically identified by the CAS number 1583-83-1, is a significant compound in the realm of organic chemistry and pharmaceutical research. This aromatic ether derivative exhibits a unique structural framework that makes it a valuable intermediate in the synthesis of various bioactive molecules. The presence of both a toluene core and a difluoromethoxy substituent imparts distinct electronic and steric properties, which are highly relevant in modern drug discovery and material science applications.

The compound's molecular structure, consisting of a benzene ring substituted with a methyl group and a difluoromethoxy group at the para position, contributes to its reactivity and utility. The electron-withdrawing nature of the difluoromethoxy moiety enhances the electrophilicity of the aromatic ring, making it susceptible to nucleophilic aromatic substitution reactions. This characteristic is particularly advantageous in constructing complex molecular architectures, which are often required in the development of novel therapeutic agents.

In recent years, 4-(Difluoromethoxy)toluene has garnered attention for its role in synthesizing fluorinated heterocycles. Fluoro-substituted compounds are increasingly prevalent in pharmaceuticals due to their improved metabolic stability, enhanced binding affinity, and altered pharmacokinetic profiles. The introduction of fluorine atoms into molecular structures can significantly modulate the properties of drug candidates, often leading to more effective and selective therapeutic outcomes. Current research focuses on leveraging the reactivity of 4-(Difluoromethoxy)toluene to develop new fluorinated derivatives with potential applications in oncology, anti-inflammatory, and antimicrobial therapies.

One notable application of this compound is in the synthesis of kinase inhibitors. Kinases are critical enzymes involved in numerous cellular signaling pathways, and their dysregulation is implicated in various diseases, particularly cancer. By incorporating fluorine atoms into kinase inhibitor molecules derived from 4-(Difluoromethoxy)toluene, researchers aim to enhance drug potency and reduce off-target effects. Preliminary studies have demonstrated that fluorinated kinase inhibitors exhibit improved pharmacokinetic profiles, including increased bioavailability and prolonged half-life.

The utility of 4-(Difluoromethoxy)toluene extends beyond pharmaceuticals into the realm of materials science. Fluoroaromatic compounds are known for their unique electronic properties, making them suitable for applications in organic electronics, liquid crystals, and advanced polymers. The electron-deficient nature of the difluoromethoxy group facilitates charge transport mechanisms, which are essential for the performance of optoelectronic devices. Consequently, this compound is being explored as a building block for developing novel materials with enhanced functional properties.

In conclusion, 4-(Difluoromethoxy)toluene (CAS No. 1583-83-1) represents a versatile intermediate with broad applications in chemical synthesis and material science. Its structural features enable the construction of complex molecules with tailored properties for pharmaceutical and industrial uses. As research continues to uncover new methodologies for fluorinated compound synthesis, the importance of this compound is expected to grow further, driving innovation across multiple scientific disciplines.

• 706-27-4(1-Methyl-4-(trifluoromethoxy)benzene)
• 705-44-2(1-Methyl-3-(trifluoromethoxy)benzene)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)